Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden · Delayed Price · Currency is SEK 0.0960
+0.0010 (1.05%)
Sep 24, 2026, 5:22 PM CET
Spago Nanomedical AB Market Cap
Spago Nanomedical AB has a market cap or net worth of 76.64 million as of September 24, 2026. Its market cap has increased by 10.06% in one year.
Market Cap
76.64M
Enterprise Value
44.14M
Revenue
3.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
ChartMarket Cap Chart
Since January 16, 2013, Spago Nanomedical AB's market cap has increased from 46.44M to 76.64M, an increase of 65.03%. That is a compound annual growth rate of 3.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 76.64M | -0.56% |
| Dec 30, 2025 | 77.07M | 12.93% |
| Dec 30, 2024 | 68.25M | -4.38% |
| Dec 29, 2023 | 71.37M | 24.57% |
| Dec 30, 2022 | 57.29M | -71.02% |
| Dec 30, 2021 | 197.67M | -26.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 108.47M |
| Nanologica AB | 100.60M |
| Biovica International AB | 90.20M |
| Alzinova AB | 86.43M |
| Ascelia Pharma AB | 82.79M |
| Pila Pharma AB | 75.15M |
| Annexin Pharmaceuticals AB | 69.89M |
| AcouSort AB | 63.07M |